Cd & M Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 27-06-2024
- Paid Up Capital ₹ 0.10 M
as on 27-06-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 19.59%
(FY 2020)
- Profit -11.74%
(FY 2020)
- Ebitda 102.45%
(FY 2020)
- Net Worth 44.88%
(FY 2020)
- Total Assets 31.78%
(FY 2020)
About Cd & M Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Seema Agarwal, Saloni Singhal, Mansi Singhal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999UP2016PTC082876
- Company No.
082876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2016
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Cd & M Remedies Private Limited offer?
Cd & M Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Anaemia Medicine, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Pharmaceutical Tablets, Respiratory System Drugs, Anti Asthma Drug, Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Cd & M Remedies?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mansi Singhal  | Director | 15-Nov-2016 | Current |
| Seema Agarwal | Director | 02-May-2016 | Current |
| Saloni Singhal | Director | 15-Nov-2016 | Current |
| Satish Agarwal | Director | 15-Nov-2016 | Current |
| Manoj Agarwal | Director | 02-May-2016 | Current |
| Vijay Agarwal | Director | 02-May-2016 | Current |
Financial Performance and Corporate Structure Insights of Cd & M Remedies.
Cd & M Remedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.59% increase. The company also saw a substantial fall in profitability, with a 11.74% decrease in profit. The company's net worth Soared by an impressive increase of 44.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cd & M Remedies?
In 2018, Cd & M Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cd & M Remedies?
Unlock and access historical data on people associated with Cd & M Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cd & M Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cd & M Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
